Here are the study facts:
"Glucagon-like peptide-1 receptor agonists promote weight loss and have demonstrated anti-inflammatory effects, including reductions in CRP. Semaglutide is a GLP-1 analogue that reduces CRP concentrations and reduces cardiovascular risk in people with type 2 diabetes."
Which came first - inflammation or insulin resistance ? It is asking the similar question of "what came first the chicken or the egg"?! We are not really sure that answer but we do know that inflammation and insulin resistance have each synergistacally thrive off each other. If someone has an imflammatory condition then there is an increased risk of insulin resistance. For best treatment overall, the benefits come when the target is to tackle both inflammation and insulin resistance at the same time to be successful at weight loss, improve cardiovascular disease, and decrease body inflammation.
The peptide weight loss injections have proven to decrease inflammation and insulin resistance. The CRP marker, known as C-Reactive Protein, is a protein that your liver makes and is measured from your blood. It is a blood test that a person would have to request since not routinely run on annual labs. It would be important to have this test run even if not obese to know your personal inflammatory levels that if elevated can increase risk for cardiovascular disease and cancers.